Skip to main content
Fig. 3 | Breast Cancer Research

Fig. 3

From: Augmented interpretation of HER2, ER, and PR in breast cancer by artificial intelligence analyzer: enhancing interobserver agreement through a reader study of 201 cases

Fig. 3

A Proportion of revisited and revised cases by artificial intelligence (AI) analyzer in Pathologist 1 (P1), Pathologist 2 (P2), and Pathologist 3 (P3). Initial and revised pathologists’ consensus of HER2 (human epidermal growth factor receptor 2) in All cases (B) or revisited cases only (C). Initial and revised pathologists’ consensus of ER (estrogen receptor) in All cases (D) or revisited cases only (E). Initial and revised pathologists’ consensus of PR (progesterone receptor) in All cases (F) or revisited cases only (G)

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us